Cannabis (Marijuana): Effects on the Brain & Body
Summary
This episode provides a comprehensive, science-based overview of how cannabis compounds — primarily THC and CBD — interact with the brain and body through the endocannabinoid system. Andrew Huberman explores different cannabis strains, their distinct effects, mechanisms of action, and the variables that determine whether cannabis is beneficial or harmful for a given individual. Key topics include creativity, memory, appetite, anxiety, hormones, and the critical importance of age and genetic predisposition.
Key Takeaways
- Cannabis contains over 70 psychoactive compounds and over 400 biologically active compounds; most research has focused only on THC and CBD.
- THC binds cannabinoid receptors with 1,000-fold greater potency than the body’s own endocannabinoids, effectively shutting down the endogenous cannabinoid system.
- Strain type and THC:CBD ratio (Type 1, 2, or 3) strongly predict effects — but individual response is still highly unpredictable.
- Sativa varieties tend to produce stimulant-like, head-centered effects (focus, elevated mood, talkativeness); indica varieties tend to produce full-body sedation and relaxation.
- There is no reliable way to predict whether a person will experience relaxation vs. paranoia from cannabis — personality or baseline anxiety level is not a predictor.
- Memory impairment (especially short-term) occurs with virtually all cannabis use regardless of strain, due to suppressed hippocampal activity.
- THC and CBD remain detectable in fatty tissue for up to 80 days after ingestion.
- Cannabis reaches peak effects within 30–60 minutes of ingestion and effects last 3–4 hours on average.
- CB1 receptors (nervous system) drive most psychoactive effects; CB2 receptors (immune system, liver, genitals) drive peripheral effects including immune modulation.
- Dependence emerges because chronic cannabis use outcompetes endogenous cannabinoids, causing anxiety, mood disruption, and sleep problems when not using.
Detailed Notes
Cannabis Strains and Varieties
- Sativa: Tall plant with long leaves; tends to produce stimulant-like, “head high” effects — elevated mood, alertness, talkativeness, narrowed focus, mild pain relief.
- Indica: Short, stout plant; tends to produce full-body relaxation, sedation, reduced insomnia, suppressed anxiety. Often remembered as “in-da-couch.”
- Ruderalis: A third variety, rarely consumed medicinally or recreationally.
- Hybrid strains: Crosses of sativa and indica in various ratios (e.g., 25/75, 50/50), increasingly engineered for specific, nuanced effects.
Type 1, 2, and 3 Classification (THC:CBD Ratio)
| Type | THC | CBD | Effect Tendency |
|---|---|---|---|
| Type 1 | High | Low | Strongest psychoactive effects |
| Type 2 | Equal | Equal | Moderate/balanced |
| Type 3 | Low | High | Minimal psychoactive; more body-focused |
- This classification applies across sativa, indica, and hybrid strains.
- Understanding this ratio is critical for predicting effects and managing dosage.
The Endocannabinoid System
- The brain and body naturally produce endogenous cannabinoids:
- Anandamide (AEA)
- 2-Arachidonoylglycerol (2-AG)
- These chemicals bind to cannabinoid receptors (CB1 and CB2), which exist from conception throughout life.
- CB1 receptors: Concentrated throughout the brain and spinal cord; responsible for most psychoactive effects.
- CB2 receptors: Found in immune tissues, liver, reproductive organs; involved in immune and peripheral biological effects.
- Endocannabinoids are retrograde signals — released from postsynaptic neurons and traveling backward to modulate presynaptic neuron activity.
- They can either increase (long-term potentiation) or decrease (long-term depression) synaptic communication depending on context.
How THC and CBD Work
- THC and CBD bind CB1 (and CB2) receptors with vastly greater affinity than endogenous cannabinoids — analogous to synthetic testosterone vs. the body’s own testosterone.
- This potency outcompetes the endogenous system, rendering it essentially non-functional during cannabis intoxication.
- The result is highly context-dependent: the same molecule can activate certain circuits (e.g., prefrontal cortex → increased focus, mood) while suppressing others (e.g., amygdala → reduced threat detection/stress).
Brain Regions Affected
- Hippocampus: Suppressed → short-term (and potentially long-term) memory impairment; universal across all strains.
- Prefrontal cortex: Activated by sativa → narrowed focus, elevated mood, reduced anxiety via brake on limbic circuits. Suppressed by indica → reduced thinking/planning, supports sleep.
- Amygdala: Generally suppressed → reduced threat detection and stress response.
- Basal ganglia & cerebellum: Suppressed → reduced physical mobility, impaired motor planning and balance.
- Hypothalamus (arcuate nucleus): High CB1 density → appetite stimulation (“the munchies”) via two mechanisms: cognitive preoccupation with food AND gut signaling that affects blood sugar.
- Spinal cord CB1 receptors: Contribute to some degree of pain relief (antinociception).
Onset, Duration, and Clearance
- Onset (smoked/inhaled): THC reaches the brain within 30 seconds via lung vasculature → bloodstream → blood-brain barrier.
- Peak effects: 30–60 minutes post-ingestion.
- Duration: 3–4 hours (varies with metabolism, familiarity, and frequency of use).
- Lipophilicity: THC and CBD are highly fat-soluble; they penetrate cell membranes and remain stored in fatty tissues.
- Detection window: Up to 80 days in fatty tissue after last use.
Common Physical Effects (Strain-Independent)
- Red eyes: Reduced lacrimal gland secretion (CB1/CB2 receptors in eyes).
- Dry mouth: Reduced saliva secretion (CB1/CB2 receptors in mouth).
- Reduced mobility: Basal ganglia and cerebellar suppression.
- Increased appetite: Hypothalamic CB1 activation + gut blood sugar signaling.
- Short-term memory impairment: Hippocampal suppression.
Anxiety and Paranoia
- Some individuals experience intense anxiety and paranoia from cannabis, even from sativa varieties intended to reduce anxiety.
- No reliable predictor exists for who will experience paranoia vs. relaxation — baseline anxiety levels are not a useful indicator.
- The idea that “using more will fix paranoia” is categorically false.
- Individual response appears consistent: if a strain causes paranoia, it is likely to do so repeatedly for that person.
- Paranoia likely results from differential CB1 activation patterns — amplifying threat circuits rather than suppressing them in susceptible individuals.
Cannabis and Creativity
- Sativa varieties and the broader effects on prefrontal cortex activation and amygdala suppression may support states of perceived creativity.
- Cannabis appears to increase convergent and divergent thinking — two components commonly associated with creative cognition.
- However, it is important to distinguish actual increases in creativity from perceived increases in creativity — these are not necessarily the same.
Dependence and Withdrawal
- Regular cannabis use suppresses the endogenous cannabinoid system.
- Upon cessation, the endogenous system cannot fully compensate, leading to:
- Heightened anxiety
- Disrupted mood
- Sleep disruption
- This mechanism explains how psychological and biological dependence develops.
Dosing Considerations
- Edibles: Allow more precise dosing (defined milligrams of THC and CBD).
- Smoked/vaped forms: Difficult to gauge exact THC/CBD